Global Market Access
Expanding into international markets presents significant opportunities for medical device manufacturers, but it also introduces additional regulatory complexity. While approvals such as CE Marking, UKCA Marking, and FDA clearance often provide a strong regulatory foundation, many jurisdictions maintain their own registration procedures, local representation requirements, and market-specific compliance obligations.
MG Regulatory supports manufacturers in developing and executing global market access strategies that facilitate efficient expansion while maintaining regulatory compliance.
Our team assists organisations in evaluating target markets, understanding local regulatory requirements, and establishing practical pathways to registration and commercialisation. By leveraging existing approvals and technical documentation where possible, we help manufacturers reduce duplication of effort and streamline international expansion programmes.
We provide support across a wide range of global jurisdictions, including Europe, the Middle East, Africa, Asia-Pacific, South Asia, and other emerging healthcare markets.
Whether entering a single new market or implementing a broader international growth strategy, our focus is on providing clear regulatory guidance, reducing barriers to entry, and helping manufacturers achieve sustainable global market access.


MG Regulatory’s project plan mapped out every step of our regulatory submission in minute detail, which kept us on track for a smooth CE mark application. When unexpected questions came back from our notified body, the team responded quickly, often within 24 hours, without compromising on quality.